proximity ligation assay
Multiple Sclerosis Progression, Disease Response Informed by Blood-Based Immune Signatures
With targeted proteomic profiling, researchers tracked down three cellular immunological subtypes showing variable disease progression features and treatment response patterns.
Alamar Biosciences Raising $128M in Series C Funding Round
The company said it plans to use the funds to accelerate commercialization of its NULISA proteomic technology.
Phase Genomics Lands $2.5M in Grants to Develop Diagnostic Score For Genomic Aberrations in Cancer
The grants include a two-year $2 million SBIR award from the National Cancer Institute and a $500,000 grant from Washington's Andy Hill Care Fund.
Using Arima's technology, NYU researchers were able to identify a novel rearrangement in the PDL-1 gene in a pediatric brain tumor, which led to treatment with immunotherapy.
The company expects its NULISA system will compete with firms like Olink and SomaLogic in the high-plex, high-throughput proteomics space.
Sep 2, 2021
Jan 24, 2020
Sep 13, 2018
Sep 2, 2011